logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Celator Pharmaceuticals, Inc.


USPTO Granted Patents = 25

% Expired Patents = 8.0



Forward Citations = 601

Loading Chart...
Loading Chart...

34 inventors (with patents filed for the assignee):

goldMedal Lawrence D Mayer (17 out of 31 patents)

silverMedal Paul Tardi (15 out of 17 patents)

bronzeMedal Murray Webb (7 out of 7 patents)

4.  Troy Harasym (6 out of 6 patents)

5.  Andrew S Janoff (6 out of 80 patents)

6.  Marcel B Bally (6 out of 48 patents)

7.  Sharon Johnstone (5 out of 5 patents)

8.  Clifford Shew (4 out of 4 patents)

9.  Yi Zeng (3 out of 3 patents)

10.  David K Watkins (3 out of 16 patents)

11.  Donna J Cabral-Lilly (3 out of 9 patents)

12.  Daryl C Drummond (2 out of 37 patents)

13.  Leon Wan (2 out of 2 patents)

14.  Winnie Lui (2 out of 2 patents)

15.  Bolin Geng (2 out of 10 patents)


Core Competencies:
Liposomal Formulations
Nanoparticle Delivery
Hematological Disorders
Drug Combinations
Lipid Vesicles
Ataxia Telangiectasia
Drug Ratios
Lyophilization
Taxane Delivery
Active Agent Release
Cytidine Analogs
Blood Stability

25 patents:

1. 12370207 - Low-intensity treatment of hematological disorders (2025-07-29),
2. 12070471 - Remote loading of sparingly water-soluble drugs into lipid vesicles (2024-08-27),
3. 11787781 - Inhibiting ataxia telangiectasia and RAD3-related protein (ATR) (2023-10-17),
4. 11746386 - Assays and methods for selecting a treatment regimen for a subject with leukemia (2023-09-05),
5. 11583544 - Remote loading of sparingly water-soluble drugs into lipid vesicles (2023-02-21),
6. 11413253 - Nanoparticle delivery systems (2022-08-16),
7. 11028076 - Inhibiting ataxia telangiectasia and Rad3-related protein (ATR) (2021-06-08),
8. 10927418 - Assays and methods for selecting a treatment regimen for a subject with leukemia (2021-02-23),
9. 10905775 - Particulate constructs for release of active agents (2021-02-02),
10. 10835492 - Method of lyophilizing liposomes (2020-11-17),
11. 10722464 - Compositions for delivery of drug combinations (2020-07-28),
12. 10285951 - Nanoparticle delivery systems (2019-05-14),
13. 10166184 - Method of lyophilizing liposomes (2019-01-01),
14. 10058507 - Compositions for delivery of drug combinations (2018-08-28),
15. 10028912 - Method of lyophilizing liposomes (2018-07-24),
Celator Pharmaceuticals, Inc. is a biopharmaceutical company based in Palo Alto, California, focused on developing innovative therapies for cancer treatment. The company specializes in the formulation and delivery of drugs that enhance the efficacy and safety of existing therapies. Celator employs advanced technologies to optimize drug combinations and improve patient outcomes. Its research initiatives are centered on addressing unmet medical needs in oncology, aiming to provide more effective treatment options for patients battling cancer.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Celator Pharmaceuticals, Inc.
25 Patents

#71 in Palo Alto, CA

#3,150 in California

#13,334 in US

#25,651 in the World

Palo Alto, CA (US)
Palo Alto, CA, United States of America

Celator Pharmaceuticals, Inc.

Forward Citations = 601

34 inventors:

goldMedal Lawrence D Mayer (17 out of 31 patents)

silverMedal Paul Tardi (15 out of 17 patents)

bronzeMedal Murray Webb (7 out of 7 patents)

4.  Troy Harasym (6 out of 6 patents)

5.  Andrew S Janoff (6 out of 80 patents)

Please report any incorrect information to [email protected]
Loading…